Gennex Laboratories Limited (BSE:531739) intends to acquire additional 6.73% minority stake in Deccan Remedies Limited on December 24, 2021. Post acquisition, will hold 51% stake in Deccan Remedies Limited. Gennex Laboratories Limited (BSE:531739) agreed to acquire additional 6.73% minority stake in Deccan Remedies Limited on January 4, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.75 INR | +1.39% | +5.15% | -0.36% |
1st Jan change | Capi. | |
---|---|---|
-0.36% | 4.56Cr | |
+51.74% | 79TCr | |
+40.45% | 63TCr | |
+17.20% | 33TCr | |
+8.96% | 30TCr | |
+17.25% | 25TCr | |
+0.41% | 22TCr | |
+10.22% | 22TCr | |
+4.46% | 16TCr | |
-6.03% | 16TCr |
- Stock Market
- Equities
- GENNEX6 Stock
- News Gennex Laboratories Limited
- Gennex Laboratories Limited agreed to acquire additional 6.73% minority stake in Deccan Remedies Limited.